Pages
Subscribe to my blog
-
Recent Blog Posts
- Indemnity for vaccine manufacturers but not Australians
- Hangover products still advertised despite complaints and lack of evidence
- COVID-19 Vaccines: Talks to U3A Melbourne City
- Complementary medicines weight loss complaints submitted to the TGA in 2018-2019. Follow-up in February 2021.
- Unnecessary, expensive and potentially dangerous supplements consumed by older Australians
- Resignation from TGACC
Themes
- ABC
- ACCC
- advertisments
- AHPRA
- AMHC
- AMI
- ARTG
- Blackmores
- Chiropractic Board
- Complaint Resolution Panel
- Complementary Medicines
- consumers
- CRP
- Dr Tom Goyer
- food-medicine interface
- FSANZ
- FSM
- Geoff Jowett
- Health Practitioner Regulation National Law Act
- health professionals
- homeopathic medicines
- Ian Rossborough
- La Trobe University
- Medical Weightloss Institute
- Medicines Australia
- MMD Review
- Monash University
- MWI
- Pharmacare Laboratories
- promotion
- Regulatory Reform
- self-regulation
- Senate Community Affairs Legislation Committee
- Souvenaid
- Swisse
- Swisse Vitamins
- TGA
- TGACC
- TGA Complaint system
- TGACRP
- Therapeutic Goods Act
- Therapeutic Goods Advertising Code
- Therapeutic Goods Amendment (2017 Measures No. 1) Bill 2017
- Transparency
- U3A
Archives
- April 2021
- March 2021
- February 2021
- November 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- October 2019
- September 2019
- August 2019
- July 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- January 2015
- December 2014
- November 2014
- October 2014
- July 2014
- March 2014
- February 2014
- January 2014
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- August 2012
- July 2012
- May 2012
- April 2012
- March 2012
- June 2011
Subscribe2
Monthly Archives: July 2013
Reconstituted CRP determines complaints against 20 Swisse products
As requested by the Federal Court, a reconstituted CRP considered again complaints 2011-11-001 and 2011-11-009 about a number of Swisse Products. In a 71 page judgement published on 4 June 2013, twenty television advertisements were reviewed for the following products: … Continue reading
How well does Australia control the promotion of therapeutic goods?
Yesterday, I gave an invited presentation to TGA staff in Canberra (and elsewhere by video-link). I reviewed how well Australia had implemented the 2007 World Health Assembly’s (WHA) Resolution 60.16: “Wishing to promote evidence-based rational use of medicines by providers and consumers, … Continue reading
CRP and TGA retraction orders revoked by AAT
In December 2010 I complained about a number of claims made in advertisements for Ethical Nutrients “Urinary Tract Support”. These included: “Urinary Tract Support contains a combination of herbs which effectively relieve the symptoms of urinary tract infections such as cystitis”. … Continue reading
Latest Nurofen complaint sent to TGA because of non-compliance
As predicted, Reckitt Benckiser (Australia) Pty Ltd have ignored the latest CRP determination. Their non-compliance has now been referred to the TGA for a Regulation 9 order. It remains to be seen what effect this will have. To my knowledge, since November 2010 … Continue reading
Posted in Uncategorized
Leave a comment
Omega 3 & Prostate Cancer
The Complementary Healthcare Council of Australia (CHC) says a study recently published in the Journal of the National Cancer Institute linking Omega-3 intake with prostate cancer is inconclusive and contradictory of a large pool of pre-existing, robust evidence that demonstrates … Continue reading
Posted in Complementary medicine
Tagged CHC, fish oil, NHS Choices, omega-3 fatty acids
Leave a comment
MJA Insight: Published:Advertising battleground
Published: https://www.mja.com.au/insight/2013/26/ken-harvey-advertising-battleground by
Posted in Complementary medicine, Natural Therapies, Pharmaceutical Promotion
Tagged Regulatory Reform, TGA
Leave a comment
CRP upholds complaints (again) about Nurofen “targeted relief”
For a nice depiction of the claims (and their craziness) see: ABC TV The Checkout: Episode 5 Also: https://theconversation.com/tga-failure-gives-nurofen-consumers-a-headache-8762 And: https://theconversation.com/targeted-pain-relief-or-targeted-marketing-the-truth-hurts-13798 The CRP’s determination is available here. A summary follows: Complaints 2012-08-010 and 2012-10-024: Nurofen Back Pain, Nurofen Migraine Pain, Nurofen Period … Continue reading
Medicines Australia Transparency Working Group Releases Reports
The documents, “Principles for transparency” and “Transparency model consultation and discussion document” are now available. For comment see: Harvey K. Slow path to transparency. MJA Insight, July 1, 2013. https://www.mja.com.au/insight/2013/24/ken-harvey-slow-path-transparency Coleman J. GPs will gain from greater transparency. 6 Minutes Q&A, July … Continue reading